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Extensive mutagenesis of the HSV-1 gB ectodomain reveals 
remarkable stability of its postfusion form
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Abstract
Viral fusogens mediate the merger of the viral envelope and cellular membrane during viral entry. 
These proteins share little sequence similarity but all are thought to act by refolding through a 
series of conformational intermediates from the metastable prefusion form to the stable postfusion 
form. Crystal structures of both prefusion and postfusion forms have illuminated the 
conformational pathways of several viral fusogens. By contrast, only the structure of the 
postfusion form is available for glycoprotein B (gB), the conserved fusogen of herpesviruses. To 
gain insight into the nature of the fusogenic conformational changes in gB, we used several 
approaches aimed at engineering the prefusion form of the HSV-1 gB ectodomain, including 
modifications intended to stabilize the prefusion form and novel mutations aimed at destabilizing 
the postfusion form. We found that the postfusion conformation of gB is remarkably stable and 
resistant to perturbations. Several mutations successfully destabilized the gB trimer, identifying 
regions that are critical for the stability of the postfusion form. Yet, none of the constructs adopted 
the prefusion conformation. We propose that the soluble ectodomain of gB folds into the 
postfusion form without first adopting the prefusion intermediate. These results suggest that other 
regions of gB, including the transmembrane region and the cytoplasmic domain, may be necessary 
to establish and maintain the metastable prefusion conformation.
© 2013 Elsevier Ltd. All rights reserved
*Corresponding author: Department of Molecular Biology and Microbiology, Tufts University School of Medicine, 136 Harrison 
Avenue, Boston, MA 02111. Phone: 617-636-0858. Fax: 617-636-0337. address: katya.heldwein@tufts.edu.
Present address: S. Sharma, Joule Unlimited Technologies, 18 Crosby Drive, Bedford, MA 01730.
ACCESSION NUMBERS
Atomic coordinates and structure factors for the gB mutant A504P/R505G/Q507G/N511G have been deposited to the RCSB Protein 
Data Bank under accession number 4HSI.
AUTHOR CONTRIBUTIONS
E.E.H. and E.V. designed the experiments and cloned the constructs, E.V., S.S., and S.D.S. expressed, purified, and characterized 
proteins, E.V. and S.S. carried out electron microscopy, S.D.S. performed and analyzed thermal denaturation experiments, E.V. 
crystallized the Quad mutant, E.E.H. determined the crystal structure of the Quad mutant, E.E.H. and E.V. analyzed the data, and 
E.E.H. wrote the manuscript.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
J Mol Biol. Author manuscript; available in PMC 2014 June 12.
Published in final edited form as:
J Mol Biol. 2013 June 12; 425(11): 2056–2071. doi:10.1016/j.jmb.2013.03.001.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Keywords
membrane fusion; viral fusogen; structure; protein engineering
INTRODUCTION
Enveloped viruses enter host cells by fusing their envelopes with the cellular plasma 
membrane or the membrane of an endocytic vesicle. This process is initiated by binding of a 
virus to its cellular receptor and is catalyzed by a viral fusogen 1. In most enveloped viruses, 
the receptor binding and the fusogenic functions are carried out by two different subunits of 
a single glycoprotein. Conformational changes in the receptor-binding subunit upon receptor 
interaction are thought to trigger fusogenic conformational changes in the fusion subunit. In 
some viruses, such as paramyxoviruses, these two functions are distributed between two 
viral proteins 2
Herpesviruses are double-stranded-DNA, enveloped viruses that cause lifelong, latent 
infections and a variety of diseases, including skin lesions, encephalitis, cancers, and 
disseminated disease in the immunocompromised and neonates. Like all enveloped viruses, 
herpesviruses penetrate cells by fusing their envelopes with a host cell membrane: either the 
plasma membrane or an endosomal membrane 3. But, the entry machinery of herpesviruses 
is more complex than that of most other viruses and consists of three conserved viral 
proteins: gB, gH, and gL, plus additional non-conserved proteins. In herpesviruses, the 
receptor-binding and the fusogenic functions are distributed among multiple proteins 4.
The mechanism of herpesvirus cell entry is perhaps best understood for the prototypical 
Herpes Simplex viruses Type 1 and 2 (HSV-1 and HSV-2). Binding of the receptor-binding 
protein gD to its cellular receptors nectin-1, herpesvirus entry mediator (HVEM), or 
modified heparan sulfate 5; 6; 7 is thought to trigger the conserved membrane fusion 
machinery composed of gB and gH/gL. Receptor-bound gD probably interacts with and 
activates gH/gL 8; 9, which in turn is thought to interact with and activate gB 10; 11. gB is 
class III viral fusogen 12; its postfusion structure shares structural similarity with the 
postfusion forms of vesicular stomatitis virus (VSV) glycoprotein G 13 and baculovirus 
gp64 14 despite lack of any sequence similarity.
Viral fusogens mediate the merger of the viral envelope and the host membrane by refolding 
through a series of conformational intermediates from the initial prefusion form to the final 
postfusion form 15. This conformational pathway has been mapped out for several viral 
fusogens from all three known classes, including influenza hemagglutinin (class I) 16, 
Dengue E (class II) 17, and VSV G (class III) 18. Crystal structures of both prefusion and 
postfusion forms of these and other viral fusogens have been invaluable in illuminating their 
membrane fusion mechanisms. Despite different architectures and lack of any sequence 
similarity, viral fusogens undergo fundamentally similar conformational changes, refolding 
from the metastable prefusion conformation into the stable postfusion conformation that 
resembles a trimeric hairpin 15.
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Understanding the structural basis for the prefusion-to-postfusion transition in gB and how it 
is triggered is one of the major challenges in the field of herpesvirus entry 3. The crystal 
structure of the recombinant HSV-1 gB ectodomain 12 probably represents the postfusion 
form because it more closely resembles the extended postfusion and not the more compact 
prefusion structure of VSV G 13; 18. But, very little is known about the structure of the 
prefusion form of gB, and, given that gB requires several additional proteins for function, it 
is unclear to what extent the fusogenic conformational changes in gB resemble those in 
other viral fusogens.
Attempts to characterize the prefusion form have been complicated by spontaneous 
refolding of the recombinantly expressed gB ectodomain into its postfusion 
conformation 12; 19; 20. Here, we have taken several approaches to engineer the prefusion 
form of HSV-1 gB. First, we have made modifications to stabilize the prefusion form of gB, 
similar to those successfully used to obtain the prefusion forms of several other viral 
fusogens 21; 22; 23; 24; 25; 26. In a novel approach, we also introduced a number of mutations 
designed to destabilize the postfusion form of gB. A large number of the resulting gB 
ectodomain constructs were characterized for antibody reactivity and the overall 
conformation. We found that the postfusion form of gB is very stable and resistant to 
structural perturbations. The remarkable stability of the postfusion form of gB probably 
provides the driving force for membrane fusion.
Mutations that successfully destabilized the gB trimer pinpoint domain dV as critical for the 
stability of the postfusion form. Yet even these mutants adopted the postfusion conformation 
instead of the prefusion conformation, supporting the idea that the soluble ectodomain of gB 
folds into the postfusion form directly without passing through a prefusion intermediate. We 
postulate that other regions of gB, including the transmembrane region and the cytodomain, 
may influence the folding energetics and are thus required for the stability of its prefusion 
conformation.
RESULTS
Mutant design
The recombinant gB ectodomain (residues 31–730) adopted the postfusion conformation 
when expressed in insect cells 12, implying that the initially formed prefusion form 
spontaneously refolded into the more stable postfusion form. To prevent or reduce 
spontaneous refolding of the gB ectodomain into the postfusion form, we used two 
orthogonal strategies: stabilization of the prefusion conformation, and destabilization of the 
postfusion conformation.
The prefusion forms of several viral fusogens have been successfully stabilized by the 
addition of C-terminal trimerization tags to the ectodomains 21; 22; 23; 24; 25; 26. To stabilize 
the prefusion form of HSV-1 gB, we used three trimerization tags: the GCN4-derived 
trimerization tag, GCNt 27; 28; the “foldon”, a C-terminal trimerization domain of T4 
fibritin 29; 30; or the cytoplasmic domain (cytodomain) of gB itself 31. GCN4 is a 
transcription factor that normally forms dimers; however, the GCN4-pII mutant forms stable 
trimers 27; 28 and thus has been used as a trimerization tag (GCNt). The 27-amino-acid 
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GCNt tag was successfully used to stabilize the soluble ectodomain of trimeric 
paramyxovirus F protein in its prefusion conformation 21. Foldon is a trimeric beta-propeller 
that can promote trimerization of heterologous proteins; it was previously used to stabilize 
the prefusion forms of HIV Env 24; 25; 26, influenza HA 22, and rabies viral fusion 
proteins 23. The gB cytodomain is trimeric 31 and is, in essence, a native trimerization tag. 
The GCNt tag, the foldon tag, or the cytodomain were placed following the last residue of 
the gB ectodomain, residue 730 (Fig. 1, Table 1). The length of the linker connecting gB 
ectodomain and tag sequences was varied. Some constructs also included the hydrophobic 
membrane-proximal region (MPR), residues 731–773 (Fig. 1, Table 1). In two constructs, 
both MPR and TM were replaced with GCNt but the cytodomain was preserved (Table 1).
The destabilizing mutations were aimed at disfavoring the formation of the postfusion 
conformation so that the ectodomain would retain the prefusion conformation. One set of 
destabilizing mutations targeted the N terminus of helix αC in domain III (dIII) of gB (Fig. 
2A) and was based on the differences between the prefusion and the postfusion structures of 
VSV G 13; 18, another class III viral fusogen. Although VSV G undergoes large 
conformational changes between the prefusion and the postfusion forms, these primarily 
involve whole domain movements with very few changes in secondary structure. The most 
significant secondary structure changes occur within dIII of VSV G (HSV-1 gB domain 
numbering scheme) where residues 263–275, mostly unfolded in the prefusion structure, 
become the N terminus of the central helix in the postfusion structure. This helix is 
stabilized by interactions with its counterparts within the VSV G trimer as well as with 
residues in domain dII (Fig. 2A). The postfusion structure of the gB ectodomain also 
contains a central helix, αC, in dIII (Fig. 2A). We hypothesized that, by analogy with VSV 
G, the N terminus of helix αC is unfolded in the prefusion form. To destabilize the helical 
conformation of the N terminus of the helix αC, we designed mutations to destabilize the 
helix itself (R515P), to disrupt its hydrogen bonds with residues in dII and dV (E502A, 
R505A, Q507A, N511A, I391P, T394P), or both (A504P/R505G/Q507G/N511G, 
henceforth referred to as Quad) (Fig. 2B, Table 1). We also designed mutations to disrupt 
side chain packing at the trimeric coiled coil interface by introducing residues with bulky 
side chains such as phenylalanine or tryptophan, or both bulky and charged lysine (L506F, 
L506K, T509F, and I513F) (Fig. 2C). Finally, two mutants combined mutations disrupting 
hydrogen bonds with mutations disrupting helical packing, A504P/R505G/L506F/Q507G/
T509F/N511G (Quad-FF) and A504P/R505G/L506W/Q507G/T509W/N511G (Quad-WW).
The other set of destabilizing mutations focused on domain dV of gB. This domain extends 
through almost the entire length of the molecule, making multiple interactions with dI, dII, 
and dIII, and is likely important for the stability of the postfusion conformation (Fig. 2E). In 
paramyxovirus fusion protein F, the postfusion structure is stabilized by a similarly extended 
domain 32 that in the prefusion structure forms an -helical stalk protruding away from the 
globular core 21 (Fig. 2D). We hypothesized that if dV forms α-helical protrusion in the 
prefusion form of gB (Fig. 2E), its modification or truncation might not affect the prefusion 
form but should destabilize the postfusion form. To test this, dV was either truncated 
(mutants gB670, gB678, gB683, gB689, gB700) or replaced with the GCNt sequence 
(mutants gB684- L10- GCNt-FactorXa-His6, gB690-L10-GCNt-FactorXa-His6, and gB701- 
L10-GCNt-FactorXa-His6, where L10 stands for linker GGSGGTGGSG) (Fig. 2F). We 
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expected that trimeric GCNt would form a trimeric coiled-coil stalk in the prefusion form, 
replacing the deleted region of dV. Finally, we made a double mutation L700G/L711G to 
destabilize helix αF in dV in the postfusion structure, expecting a lesser destabilizing effect, 
if any, on the prefusion conformation.
The majority of gB mutant ectodomains are secreted
All gB constructs were expressed in Sf9 cells infected with recombinant baculoviruses. All 
proteins were secreted into culture media except gB684-L10-GCNt-Xa-His6, gB690-L10-
GCNt-Xa-His6, and gB701-L10-GCNt-Xa-His6, suggesting that they were misfolded (Fig. 
3, Table 1). These mutants were not pursued further.
Several mutations destabilize the trimer and abolish DL16 reactivity
To test if any of the mutants adopted the prefusion conformation, we performed using SDS-
PAGE under mildly denaturing conditions and Western blot analysis with two anti-gB 
monoclonal antibodies, DL16 and C22633. Although a panel of neutralizing monoclonal 
antibodies with known epitopes, many of which are conformational, is available 33, all of 
these antibodies also bind the postfusion ectodomain 33, which is not surprising considering 
that their epitopes are exposed on the surface of the postfusion form 12. Thus none of these 
antibodies can be expected to reliably distinguish the prefusion form from the postfusion 
form. By contrast, the non-neutralizing mAb DL16 does not only recognize a 
conformational epitope but also requires the intact postfusion trimer: DL16 does not bind 
monomeric gB. Moreover, the DL16 epitope, which encompasses domains dI and dV, is 
very sensitive to disruptions 19; 33. The prefusion form of gB is expected to differ 
substantially from its postfusion form, considering that the known structures of the two 
forms in other viral fusion proteins are very different 15; 34. Given the high specificity of 
DL16 for the postfusion trimer, particularly, the high sensitivity of its epitope to even small 
conformational changes, we hypothesized that the DL16 antibody is highly unlikely to 
appreciably bind the prefusion form or any form other than the postfusion form. This was 
our rationale for using DL16 as a postfusion-form-specific reagent.
Under mildly denaturing SDS-PAGE conditions, the postfusion HSV-1 gB ectodomain, 
gB730, migrates as a high-molecular weight band that corresponds to a trimer (Fig. 4). This 
band reacts with the trimer-specific DL16. Lack of reactivity with DL16 was taken to mean 
that a gB mutant likely adopted a conformation different from the postfusion one (Table 1). 
All mutant proteins were also tested for their reactivity with the mAb C226 (Table 1). This 
antibody recognizes a conformational epitope within dII and reacts with both trimeric and 
monomeric species on SDS-PAGE. While C226 reacts with the postfusion conformation of 
the gB ectodomain, it is a neutralizing antibody and should react with the prefusion form as 
well. Reactivity with C226 was used to test for proper folding and trimerization of mutants 
not recognized by DL16.
Under mildly denaturing SDS-PAGE conditions, all gB mutants designed to stabilize the 
prefusion form migrated as oligomers similar in size to the WT gB730 trimers (Fig. 4A). All 
mutants from this category reacted with both C226 and DL16 antibodies, indicating that the 
presence of GCNt or foldon sequences did not affect their respective epitopes (Fig. 4A). 
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Moreover, DL16 reactivity suggested that these mutants retained the trimeric postfusion 
conformation of WT gB730. All 6 mutants containing the cytodomain were less stable 
trimers than gB730 (Fig. 4A).
Among mutants designed to destabilize the postfusion conformation, all but nine had WT 
gB730 electrophoretic mobility on mildly denaturing SDS-PAGE (Fig. 4B). The nine 
mutants that did not were T394P, gB670, gB678, gB683, gB689, gB700, L700G/L711G, 
Quad-FF and Quad-WW. Mutant T394P showed only high molecular weight species that 
entered the gel poorly and was not characterized further. Truncation mutants gB670, gB678, 
gB683, gB689 and gB700 migrated primarily as monomers (Fig. 4B). Truncations of dV 
thus destabilized the trimeric gB ectodomain. Weak trimer bands were seen for gB678, 
gB683, and gB689 but these did not react with DL16 probably because truncations of dV 
affected the DL16 epitope. Mutants L700G/L711G, Quad-FF, and Quad-WW also formed 
less stable trimers, and only Quad-FF reacted with DL16 (Fig. 4B). Because of the change in 
their electrophoretic and antigenic properties, mutants gB670, gB678, gB683, gB689, 
gB700, L700G/L711G, and Quad-WW were considered the most promising and were 
characterized further.
Purification of mutant protein constructs
We purified all mutant proteins with reduced DL16 reactivity and several mutant proteins 
with WT reactivity, namely, gB730-GSGS-foldon, gB730- L10-GCNt-Xa-H6, gB730-
GCNt-cyto(821-904), gB730-L10-cyto(796-904)-His6, R505A, I391P, L506F, T509F, and 
Quad. Most mutants were purified using immunoaffinity chromatography with immobilized 
DL16 or C226 mAb followed by size-exclusion chromatography, except Quad-WW and 
mutants with truncated dV. As expected, all mutants with WT DL16 reactivity as well as 
mutant L700G/L711G eluted near the same elution volume as WT gB730 (Fig. 5).
gB mutants with truncated dV (gB670, gB678, gB683, gB689, and gB700) and Quad-WW 
were purified by gravity flow instead of peristaltic flow, to reduce aggregation. All truncated 
mutants were purified using Ni-NTA metal affinity chromatography, made possible by a 
histidine patch on the surface of the gB ectodomain, followed by immunoaffinity 
chromatography with immobilized C226 mAb and by hydroxyapatite chromatography. 
Quad- WW mutant was purified using Ni-NTA metal affinity chromatography followed by 
hydroxyapatite chromatography, in the presence of the detergent CHAPS during all 
purification stages.
All mutants adopt the WT postfusion conformation
The gB730 ectodomain represents the postfusion conformation 12; 35 and has a characteristic 
shape with distinct “crown” and “base” ends that can be easily discerned by negative-stain 
electron microscopy (EM) 19; 20. Detection of this shape in mutant proteins was used as a 
definitive test of the postfusion conformation. As expected, all DL16-reactive constructs 
adopted the WT postfusion conformation: R505A, I391P, L506F, gB730-L10-GCNt-Xa-H6, 
gB730-GCNt-cyto(821-904), gB730-GSGTGS-cyto(796-904), gB730-GSGS-foldon (Fig. 
6A–G), T509F, and Quad (data not shown). Despite the lack of DL16 reactivity, both 
L700G/L711G and Quad-WW mutants adopted the WT postfusion conformation (Fig. 6H–
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I), indicating that in these two mutants, the DL16 epitope was disrupted by local rather than 
global conformational changes.
Mutant gB670 formed rosettes with 3 to 5 arms (Fig. 6J). The length of each arm was 17.2 ± 
0.5 nm (n=9), which is similar to the length of HSV-1 gB ectodomain calculated from its 
atomic coordinates (16.7 nm) 12; 20. Moreover, the characteristic “crown” shape at the tip of 
each arm (Fig. 6J) resembled the “crown” end of the HSV-1 gB ectodomain in EM 
images 19; 20 and the crystal structure 12; 20 (Fig. 6K). This overall shape similarity 
suggested that gB670 adopted the postfusion gB conformation and that each rosette was 
composed of several gB trimers joined by their “base” ends. Unlike gB670, WT gB730 does 
not form rosettes. We hypothesize that truncation of domain dV in gB670 causes local 
conformational changes in dI, which interacts extensively with dV, causing normally buried 
hydrophobic residues to become exposed at the “base” end and to form rosettes. gB670 
rosettes resemble rosettes formed by the ectodomains of gB from EBV 36; 37 and HCMV 38, 
which contain exposed hydrophobic residues in their fusion loops which are located at the 
tips of domains dI, indirectly supporting the above hypothesis. Although truncations of dV 
caused local conformational changes in the vicinity of the fusion loops and the DL16 
epitope, none affected the global conformation of the gB ectodomain.
Mutations in dV reduce overall stability of the gB ectodomain
To assess the overall stability of the purified gB mutants, we carried out thermal 
denaturation studies using circular dichroism (CD) (Fig. 7A). CD signal provides an 
estimate of the secondary structure content. Due to a high β-strand content of the gB 
ectodomain, the CD signal at 218 nm (θ218) was used to monitor folding. The decrease of 
θ218 signal with increasing temperature reflects unfolding of the secondary structure. We 
found that gB730 was highly resistant to thermal denaturation, with a melting temperature 
(Tm) of 78.2±0.7°C. Since the Quad-WW mutant and mutants with truncated dV aggregated, 
we could not analyze their stability using CD. Instead, we chose to test mutants L700G/
L711G and gB730-GCNt-cyto(821-904) because they appeared to form less stable trimers in 
Western blots of insect cell supernatants (Fig. 4). We found that gB730-GCNt- 
cyto(821-904) was slightly more resistant to denaturation than gB730 and had Tm = 
79.5±0.7°C, which is consistent with the stabilizing effect of trimeric GCNt. By contrast, 
mutant L700G/L711G was noticeably less stable, with a Tm of 72.1±0.7°C. The stability of 
the ectodomain was thus sensitive to mutations in dV.
To obtain an additional assessment of the overall protein stability, we used the Thermofluor 
assay, which determines protein stability by monitoring the exposure of hydrophobic regions 
during unfolding by measuring binding of a hydrophobic dye 39(Fig. 7B). The Tm values 
estimated by Thermofluor were slightly higher for all proteins than those estimated from CD 
but remained consistent: gB730 had a Tm = 80.2±0.1°C, while gB730-GCNt-cyto(821-904) 
was more stable than the WT, with Tm = 81.7±0.2°C, and mutant L700G/L711G was less 
stable than the WT, with Tm = 75.5±0.1°C.
While assaying protein resistance to thermal denaturation by measuring either the CD signal 
or the binding of a hydrophobic dye provides an estimate of the overall protein stability, it 
does not directly test stability of the trimer. To correlate the overall stability of the 
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ectodomain with the trimer stability, we analyzed the purified proteins on mildly denaturing 
gels (Fig. 7C). Similarly to gB730, both gB730-GCNt-cyto(821-904) and L700G/L711G 
migrated as trimers on SDS-PAGE under mildly denaturing conditions. This result contrasts 
with our observations of protein stability in supernatants where gB730-GCNt-cyto(821-904) 
and L700G/L711G migrated as both trimers and monomers (Fig. 4). One possible 
explanation could be the difference between slightly acidic pH of the insect cell media (pH 
6.1–6.4) as opposed to pH 8.0 of the purified protein storage buffer. Low pH affects the 
electrophoretic mobility of gB730 under mildly denaturing conditions: while at pH 8.0, only 
the trimer band can be detected; at pH 6.0 both the monomer and the trimer can be observed; 
and at pH 5.0 only the monomer and not the trimer can be detected 20. This effect has been 
attributed to the destabilizing effect of the low pH on the trimeric gB ectodomain, which in 
combination with SDS and electric current causes trimer dissociation 20. Regardless of the 
cause of trimer dissociation of protein in viral supernatants, both mutants form stable trimers 
when they are purified, which is in agreement with thermal denaturation studies (Fig. 7A, 
B).
Importantly, both truncation mutant gB670 and the Quad-WW mutant primarily migrated as 
monomers under mildly denaturing conditions (Fig. 7C). Reduced trimer stability of these 
mutants as purified proteins demonstrates that the trimeric gB ectodomain is sensitive to 
deletions of dV and large perturbations of the coiled-coil interface.
A504P/R505G/Q507G/N511G mutations do not perturb the central helix αC
To understand how the gB ectodomain can maintain a postfusion conformation despite the 
presence of multiple destabilizing mutations within helix αC of dIII, we determined the 
crystal structure of the gB Quad mutant (Fig. 8A). Although proline and glycine residues are 
known to introduce kinks or breaks into helices 40; 41; 42, the mutation of three amino-acid 
residues to glycines and one to a proline within the N terminus of helix αC did not change 
its overall conformation (Fig. 8A), probably because it is restricted by the neighboring 
domains dII and dV. The conformational changes within helix αC were limited to two side 
chains. The side chain of F503 in the Quad mutant switched its rotamer, relocating into the 
empty space introduced by elimination of the side chain of R505 (Fig. 8C). The side chain 
of E502 also relocated (Fig. 8C) but probably not as a consequence of any of the mutations 
in the gB Quad mutant because this alternative conformation of the E502 side chain has 
been observed in other gB structures. Thus, the introduction of multiple glycine and proline 
residues was not sufficient to destabilize the N-terminus of helix αC. Initial analysis of the 
WT gB730 structure suggested that the hydrogen bonds between the side chains of R505, 
Q507, and N511 and domains dII and dV could stabilize helix αC. Although mutations 
R505G, Q507G, and N511G disrupted the majority of hydrogen bonds between the N 
terminus of helix αC and domains dII or dV (Fig. 8D), they did not destabilize the helix, 
probably because the backbone hydrogen bonds are sufficient for its stability.
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DISCUSSION
The postfusion conformation of gB is very stable
Overall, it was very difficult to destabilize the trimeric postfusion form of gB ectodomain as 
it was resistant to perturbations by a number of approaches used here. Introducing glycines 
and prolines into the N terminus of central helix αC, which forms the coiled-coil core of the 
postfusion trimer, did not destabilize even helix αC itself, let alone the trimer. Likewise, 
mutations disrupting hydrogen bonds between the N terminus of helix αC and dII or dV did 
not have any obvious effect on the formation of the postfusion gB trimer. The T394P mutant 
aggregated under SDS-PAGE conditions, so the T394P mutation probably destabilized the 
protein (T394 is located within a β-strand), but because this mutant was not amenable to 
purification and biochemical characterization we could not assess the effect of the mutation 
on stability directly.
Initially, we expected that introducing bulky residues at the coiled coil interface within the N 
terminus of helix αC would successfully destabilize the trimer given the tight side chain 
packing at the coiled coil interface. We found, however, that none of the single 
phenylalanine or lysine mutations, each of which introduced three bulky side chains at the 
trimeric coiled coil interface, destabilized the postfusion trimer. Only a double 
phenylalanine and especially double tryptophan mutations (Quad-FF and Quad-WW), which 
introduced six bulky side chains at the coiled coil interface, destabilized the trimer to some 
extent. Nevertheless, even these mutations failed to prevent the formation of the postfusion 
form. These observations point to remarkable elasticity of the gB ectodomain, which can 
accommodate a number of mutations without a deleterious effect on its overall structure. 
This elasticity manifested itself in the relocation of the F303 side chain in the Quad mutant 
to compensate for the removal of the R505 side chain.
Truncations of dV and, to a lesser extent, the L700G/L711G double mutation destabilized 
the trimeric postfusion form of the gB ectodomain. dV is not an independently folded 
domain but rather a long extension spanning nearly the entire length of the ectodomain (Fig. 
2E). Residues within dV have no contact with the rest of the polypeptide chain of the same 
protomer and instead make multiple contacts with domains dI, dII, and dIII of the other two 
protomers within the trimer, which strengthens trimer interactions. dV plays an important 
role in the stability of the postfusion trimer, and it is not surprising that truncations of dV 
destabilize the trimer. Nevertheless, even the complete removal of dV in mutant gB670 did 
not abrogate the formation of the postfusion trimer. This suggests that multiple regions 
within the molecule contribute to the stability of the postfusion conformation such that 
perturbation of any single region is not sufficient to destroy the postfusion conformation 
completely. The remarkable stability of the postfusion form of gB probably provides the 
driving force for membrane fusion.
Lack of DL16 reactivity does not reliably indicate the absence of the postfusion 
conformation
DL16 is a conformational antibody that specifically recognizes the postfusion gB trimer and 
can serve as an indicator of the postfusion conformation. The DL16 epitope must span at 
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least two protomers and probably includes residues within domains dI and dV 33 because it 
is sensitive to mutations within these domains. For example, a 5-amino-acid residue 
insertion after a buried residue E187 in dI abrogated DL16 binding 19. Here, we found that 
the L700G/L711G double mutation, all partial and full truncations of dV, and the L506W/
T509W double mutation in the Quad-WW mutant affected the DL16 epitope. Although the 
Quad-WW mutant also contains mutations A504P/R505G/Q507G/N511G, these four 
mutations did not affect the DL16 epitope in the Quad mutant. Residues L700 and L711 lie 
within domain dV, buried underneath the putative DL16 epitope, and probably buttress 
domain dI by interacting with several residues in this domain. Substitution of L700 and 
L711 with glycines likely caused local conformational changes in dI that disrupted the DL16 
epitope. Truncations of domain V had a more direct effect on the DL16 epitope, probably by 
removing a part of it. It is harder to explain why mutations L506W/T509W disrupted the 
DL16 epitope given that residues L506 and T509 are located far from its putative location 
within domains dI and dV. We hypothesize that the L506W/T509W double mutation 
probably splayed apart the trimeric coiled coil and that these conformational changes 
propagated to dI and dV, disrupting DL16 binding. While DL16 reactivity is a reliable 
indicator of the postfusion conformation, the high sensitivity of the DL16 epitope to 
proximal as well as distal structural perturbations leads us to conclude that the absence of 
DL16 reactivity cannot be taken as the absence of the postfusion form.
The soluble ectodomain folds into the postfusion conformation directly
While it was possible to destabilize the postfusion conformation, none of the mutants 
adopted the prefusion conformation or any conformation other than postfusion. Surprisingly, 
addition of the trimerization tags GCNt and foldon, which successfully stabilized the 
prefusion forms of other viral fusion proteins 21; 22; 23; 24; 25; 26, did not yield the prefusion 
form of gB. We have some indirect evidence that the TM helices of gB probably do not 
interact within the plane of the membrane 43. Replacing the native, non-trimerizing, TM 
sequence in the context of full-length gB constructs with trimerizing GCNt or foldon may 
interfere with proper folding of the prefusion form, which may potentially explain why 
trimeric GCNt and foldon are poor substitutes for the native TM sequence. More puzzling is 
the inability of GCNt and foldon sequences to lock the isolated gB ectodomain into its 
prefusion form even in the presence of long linkers connecting the gB and the GCNt (or 
foldon) sequences. We hypothesize that the folding pathway for the soluble gB ectodomain 
produces the postfusion form directly, without a prefusion intermediate. That is, when 
expressed on its own, the gB ectodomain folds into the stable postfusion form without first 
adopting the metastable prefusion conformation.
In support of this, three mutants in which various regions of dV were replaced with GCNt 
were not secreted, probably due to misfolding. This substitution cannot be accommodated in 
the postfusion form and would lead to misfolded protein; yet, we expected that it would be 
tolerated in the prefusion form, possibly stabilizing it. Although we cannot exclude the 
possibility that the GCNt substitution of dV cannot be tolerated in the prefusion form, our 
preferred explanation for misfolding of these constructs is that they fold into the postfusion 
conformation directly.
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The observed inability of the soluble gB ectodomain to adopt the prefusion conformation 
suggests that that other regions of gB, including the transmembrane region and the 
cytoplasmic domain, may be necessary to establish and maintain the metastable prefusion 
conformation. The presence of the transmembrane region is particularly important 
considering that all constructs containing the cytoplasmic domain in addition to the 
ectodomain adopted the postfusion conformation. Future efforts to obtain the prefusion 
conformation of gB should focus on full-length gB. Alternatively, interactions with other 
viral proteins, such as gH/gL, may be critical to maintaining the gB prefusion form at the 
virion surface.
MATERIALS AND METHODS
Cloning
HSV-1 (strain KOS) gB was used in all cloning. Point, truncation and insertion mutants 
were generated by “splicing by overlap extension” PCR (SOE-PCR) method 44. Resulting 
PCR products were subcloned into the gB gene (residues A31–A730) in vector pFastBac1. 
In all signal sequence was replaced with the signal sequence from honeybee constructs, the 
endogenous melittin, to improve secretion. The resulting plasmids are pKH1 (gB773-
foldon), pKH2 (gB773- GCNt), pKH6 (gB730-GSGS-foldon), pKH8 (gB730-GSGTGS-
foldon-Xa-His6), pKH10 (gB730-GGSGGTGGSG-foldon-Xa-His6), pKH11 (gB773-
GGSGGTGGSG-cyto(796-904)-His6), pKH12 (gB730-GSGTGS-cyto(796-904)-His6), 
pKH13 (gB730-GGSGGTGGSG- cyto(796-904)-His6), pKH14 (gB773-GSGTGS-GCNt-
Xa-His6), pKH15 (gB730-GSGTGS- GCNt-Xa-His6), pKH17 (gB730-GGSGGTGGSG-
GCNt-Xa-His6), pKH19 (gB773-GSGTGS- foldon), pKH20 (gB773-GGSGGTGGSG-
foldon), pKH21 (gB773-foldon-strep), pKH22 (gB773-GSGTGS-foldon-strep), pKH23 
(gB773-GGSGGTGGSG-foldon-strep), pKH30 (L506F), pKH31 (I513F), pKH34 (gB730-
GSGTGS-cyto(796-904)), pKH35 (T509F), pKH36 (R515P), pKH78 (gB684-
GGSGGTGGSG-GCNt-Xa-His6), pKH79 (gB690-GGSGGTGGSG- GCNt-Xa-His6), 
pKH80 (gB701-GGSGGTGGSG-GCNt-Xa-His6), pDM1 (gB773-GSGTGS- cyto(796-904)-
His6), pEV1 (R505A), pEV2 (E502A), pEV3 (Q507A), pEV4 (I391P), pEV5 (L506K), 
pEV6 (N511A), pEV8 (L700G/L711G), pEV9 (gB670), pEV10 (gB689), pEV11 (gB678), 
pEV12 (gB683), pEV13 (gB700), pEV18 (A504P/R505G/Q507G), pEV19 (A504P/R505G/
Q507G/N511G), pEV21 (T394P), pEV29 (A504P/R505G/L506W/Q507G/T509W/N511G), 
pEV30 (A504P/R505G/L506F/Q507G/T509F/N511G), pEV35 (gB730-GCNt-
cyto(821-904), pEV36 (gB730-GCNt-cyto(796-904).
Antibodies
Hybridoma cell lines expressing anti-HSV-1 gB monoclonal antibodies (mAbs) DL16 or 
C226 were a gift from Drs. Roselyn J. Eisenberg and Gary H. Cohen (University of 
Pennsylvania). The mAbs were purified at the GRASP facility at Tufts Medical Center. 
DL16 is a conformational mAb that recognizes the trimeric form of the HSV-1 gB 
ectodomain 33. C226 is a neutralizing antibody that recognizes a conformational epitope 
located in domain II of HSV-1 gB ectodomain 33. Polyclonal antibody R68 was a gift from 
Drs. Roselyn J. Eisenberg and Gary H. Cohen (University of Pennsylvania).
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Viruses and cells
Spodoptera frugiperda (Sf9) cells were grown in SF-900 II SFM (Invitrogen) in suspension 
at 27°C. All recombinant baculoviruses for gB expression were generated using Bac-to-Bac 
technology (Invitrogen). Sf9 cells were transfected with each recombinant bacmid DNA and 
passage 1 (P1) viral stock was harvested at 72 hours post transfection. After two rounds of 
amplification, passage 3 (P3) stocks of baculoviruses were harvested and stored at 4°C in the 
dark in the presence of 2% FBS.
Protein expression and purification
Initially, expression was tested in P1 “refeed” supernatants made by incubating infected 
cells in fresh media for 72 hours after harvesting P1. For large-scale protein expression, P3 
stocks of baculoviruses were used to infect Sf9 cells. The amount of viral inoculum was 
optimized to yield the highest protein expression. Typically, 10 mL of viral stock was added 
to 1 L of SF9 cells at 1.5×106 cells/mL, and cell supernatants were harvested 72 hours post-
infection. Cells were pelleted using centrifugation at 3750 rpm at 4°C for 20 minutes. The 
supernatant was collected, filtered through a 0.22 μm filter, and concentrated using a 
Tangential Flow Filtration system (Millipore) using a 30-kDa PLTK cartridge (Millipore). 
Buffer exchange was done three times into phosphate-buffered saline pH 7.4 to remove 
media components, and 0.1 mM PMSF was added to inhibit proteolytic activity.
With few exceptions, all gB mutants were purified by immunoaffinity chromatography 
using mAb DL16 immobilized on CNBr-activated Sepharose 4B (GE Healthcare) according 
to the protocol developed earlier for the purification of WT gB73012. Mutant L700G/L711G 
was purified by immunoaffinity chromatography using immobilized mAb C226 instead of 
DL16. After extensive washing with 10 mM Tris-HCl, pH 8.0, and 500 mM NaCl, the 
protein was eluted with 3M KSCN and concentrated on an Amicon Ultra-15 concentrator 
(Millipore) with a 50-kDa MW cutoff. Proteins were further purified by size-exclusion 
chromatography using Superdex S200 column (GE Healthcare) equilibrated with 20 mM 
Tris (pH 8.0), 150 mM NaCl, and 1 mM EDTA. The column was calibrated using blue 
dextran (~2000 kDa), thyroglobulin (667 kDa), ferritin (440 kDa), catalase (232 kDa), and 
aldolase (158 kDa).
gB mutants with truncations in domain dV were purified by Ni-NTA metal affinity 
chromatography (GE Healthcare) in 50 mM Tris-HCl, pH 8.0, 300 mM NaCl. Proteins were 
eluted from the Ni-NTA resin with 250 mM Imidazole in 50 mM Tris-HCl, pH 8.0, 300 mM 
NaCl. After buffer exchange into 50 mM Tris-HCl, pH 8.0, 300 mM NaCl, protein was 
further purified by immunoaffinity chromatography using immobilized mAb C226. Protein 
eluted from the immunoaffinity column was exchanged into 10 mM sodium phosphate, pH 
7.5, 50 mM NaCl, loaded onto a hydroxyapatite column equilibrated in the same buffer, and 
eluted using a gradient of sodium phosphate, pH 7.5. All chromatography steps were done 
using gravity flow instead of the peristaltic pump, to reduce aggregation.
The A504P/R505G/L506W/Q507G/T509W/N511G (Quad-WW) mutant was purified by 
Ni-NTA metal affinity chromatography followed by hydroxyapatite column. 0.1% detergent 
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CHAPS was added to all solutions during purification to reduce protein aggregation. All 
chromatography steps were done using gravity flow.
SDS-PAGE and Western blot analysis
Three conditions were used in preparation of samples for SDS-PAGE: mildly denaturing 
(0.1% SDS, no reducing agent, no boiling), non-reducing denaturing (1% SDS, no reducing 
agent, boiling), and reducing denaturing (1% SDS, reducing agent, boiling). To test 
expression by Western blot analysis using pAb R68, samples were prepared under reducing 
denaturing conditions. To test reactivity of gB mutants with conformational mAbs, samples 
were prepared under mildly denaturing conditions to preserve gB oligomers.
For Western blot analysis, protein samples were resolved by SDS-PAGE (4–15% 
acrylamide gel, Bio-Rad) and transferred to a nitrocellulose membrane. Membranes were 
blocked with 5% skim milk in Tris-buffered saline containing 0.05% Tween-20. To test the 
expression of gB constructs, membranes were probed with a pAb R68 at a 1:10,000 dilution, 
followed by incubation with a secondary anti-rabbit IgG conjugated to horseradish 
peroxidase at a 1:10,000 dilution. To test for reactivity with conformational antibodies, 
membranes were probed with a mAb DL16 at a 1:1,000 dilution or a mAb C226 at a 1:5,000 
dilution, followed by incubation with a secondary anti-mouse IgG conjugated to horseradish 
peroxidase at a 1:10,000 dilution. Blots were developed using a Western Pico 
chemiluminescence kit (Pierce).
Electron microscopy
Purified protein samples (5 μM) were incubated on glow-discharged formvar/carbon-coated 
200 mesh copper grids (SPI) at room temperature and stained with 0.75% solution of uranyl 
formate. EM images were obtained at room temperature using a Tecnai G2 Spirit BioTWIN 
equipped with an AMT 2k charge-coupled device camera microscope at the Harvard 
Medical School EM core facility.
Thermal Denaturation using Circular Dichroism (CD) Spectroscopy
Measurements were acquired using a JASCO-810 spectropolarimeter equipped with Peltier 
cell (Elfin model ELDC5D4) and a 1 cm quartz cuvette. Thermal denaturation was 
monitored at 218 nm (θ218). All measurements were performed in 20 mM phosphate pH 8.0 
and 100 mM NaF using protein at a concentration of 0.2 mg/ml, as determined by 280 nm 
absorbance (Nanodrop ND-1000). 218 nm measurements were taken every 0.1°C with an 8 s 
response time and 1 nm width. Rapid heating of wild-type gB and mutants at 2°C/min was 
used to identify temperatures where each began to denature. Final melting curves were 
obtained by slow heating (0.1°C/min) starting at least 2°C below where protein started to 
denature. Melting curves were processed for noise elimination by averaging CD signals 
from all points in a 6°C range for each measurement. Each θ218 measurement was converted 
to fraction unfolded (Funf) using the equation: (θ218 − θU)/(θF − θU), where θ218 is the 
observed ellipticity at 218 nm for a given temperature, θU is the θ218 value when the protein 
is unfolded and θF is the θ218 value when the protein is folded. The θU and θF values were 
determined in each experiment by averaging unsmoothed θ218 from all readings spanning at 
least 5°C at temperatures either just prior to (θF) or just after (for θU) protein melting. The 
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Tm was obtained from the point of the melting curve corresponding to Funf = 0.5. A 95% 
confidence interval for θ218 at the Tm was calculated by combining standard error of the 
baselines, converting this error to a Tm range using smoothed θ218 values, and then adding 
the error range of the Peltier unit (accurate to 0.6°C) to that range.
Thermal Denaturation with Thermofluor
The Thermofluor assay 45 uses a fluorescent dye which gives an enhanced signal upon 
exposure to hydrophobic environments. As the temperature is raised, the protein is 
denatured, exposing hydrophobic regions to which the dye binds. This causes an increase in 
the dye fluorescence. Protein was diluted into 20 mM sodium phosphate pH 8.0 and 100 
mM NaF to a final concentration of 0.15 mg/ml, approximately 10-fold. SYPRO Orange 
(Invitrogen), the fluorescent dye, was added at a 1:2000 dilution. Each experiment was done 
in triplicate by aliquoting 20 μl samples into a 96-well PCR microplate, which was sealed 
and then centrifuged for 1 minute at 500 g at 23°C. Samples were analyzed in a Roche Light 
Cycler 480 qPCR instrument using an excitation wavelength of 465 nm with emission 
detected at 610 nm. The emission signal was analyzed from 23°C to 95°C at a continuous 
acquisition rate of 3 measurements per C. The raw spectra of fluorescence vs temperature 
were converted to the first derivative spectra, and Tm was determined as the temperature 
corresponding to the maximum value in the first derivative spectrum. The reported Tm 
represents the average of 3 experiments. Reported errors represent the standard deviation.
Crystallization, data collection, and structure determination of the A504P/R505G/Q507G/
N511G (Quad) mutant
For crystallization, gB mutant protein in 10 mM Tris·HCl, pH 7.6, 100 mM NaCl, and 1 mM 
EDTA was concentrated to 4.0 mg/mL using a Millipore Ultra-4 concentrator (MW cutoff 
50 kDa). Crystals were grown by vapor diffusion at room temperature in hanging drops with 
2 μl protein sample and 2 μl reservoir solution containing 15% PEG 4000, 0.2 M NaCl, and 
0.1 M Na·citrate, pH 5.5. Hexagonal rods appeared after several days and grew to their final 
size over 2–3 weeks. For data collection, crystals were transferred stepwise to a solution 
identical to the well solution plus 15% mesoerythritol, 0.1 M NaCl, and 1 mM EDTA and 
plunged into liquid N2. Data for the mutant crystals were collected at 100 K at X25 beamline 
at the National Synchrotron Light Source. The dataset was processed using HKL200046 and 
indexed in space group P3 (Table 2). Prior to refinement, 5% of the data were set aside for 
cross-validation by transferring test set flags from the 3NWA dataset 20 to the A504P/
R505G/Q507G/N511G mutant dataset. The 3NWA coordinates were used as a starting 
model for refinement of the A504P/R505G/Q507G/N511G mutant structure except that 
residues 500–515 were omitted. Model was refined using phenix. refine 47 with iterative 
rounds of rebuilding in Coot 48. The omit density was used to rebuild the conformation of 
residues 500–515. Molprobity 49 was used to assess the stereochemical quality of all 
models. Final statistics are listed in Table 2. The final model is missing residues 28-104, 
474-491, and 724-730 in chain A; residues 28-102, 259-261, 478-490, and 725-730 in chain 
B; residues 28-104, 474-491, and 725-730 in chain C; and residues 28-102, 259-260, 
479-493, and 725-730 in chain D. The final model contains carbohydrate moieties (N-
acetylglucosamine) modifying residues N398 and N430 in chains A and C, and residues 
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N398 and N674 in chains B and D, as well as 2 molecules of mesoerythritol, a 
cryoprotectant.
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Highlights
The ectodomain of herpesvirus fusogen gB spontaneously folds into the postfusion 
form
Postfusion conformation of gB is remarkably stable and resistant to perturbations
Domain dV is critical for the stability of the postfusion form
The isolated gB ectodomain folds into postfusion form without prefusion 
intermediate
The TM and the cytodomain may be necessary to maintain the metastable prefusion 
form
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Fig. 1. 
Schematic view of the sequence of the full-length HSV-1 gB and constructs designed to 
stabilize the prefusion conformation. SS – signal sequence, MP – membrane-proximal 
region, TM – transmembrane region, Cyto – cytoplasmic domain are shown as rectangles of 
different shades of gray. GCNt (sequence: QIEDKIEEILSKIYHIENEIARIKKLIGE) and 
foldon (sequence: GYIPEAPRDGQAYVRKDGEWVLLSTF) are shown as black 
rectangles. Linkers GSGS, GSGTGS, or GGSGGTGGSG are shown as lines.
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Fig. 2. 
Regions targeted for mutagenesis. (A–C) Central coiled coil region as a target for 
mutagenesis. (A) The N terminus of the central alpha helix that undergoes refolding in VSV 
G is shown in magenta in the crystal structures of the prefusion and postfusion forms of the 
trimeric ectodomain 13; 18. The analogous region in the crystal structure of the postfusion 
form of HSV-1 gB ectodomain 12 is also shown in magenta. Domains in VSV G are labeled 
using gB domain numbering scheme, for clarity. Insets show close-up views of this region 
within single protomers. (B) A close-up view of the hydrogen bonds between the N-
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terminus of the central -helix αC in domain dIII (magenta) and domains dII and dV. 
Residues involved in hydrogen bonds are shown as sticks and labeled. Hydrogen bonds are 
shown as dashed lines. (C) Three symmetry-related C helices within the central coiled coil 
are shown in a top-to-bottom view. Residues L506, T509, and I513 at the coiled-coil 
interface are shown as sticks in all three protomers but labeled only in one protomer. (D–F) 
Domain dV as a target for mutagenesis. (D) A C-terminal helix in the ectodomain of 
paramyxovirus F protein, analogous to domain dV in HSV-1 gB, is shown in orange in the 
prefusion structure of PIV5 F and the postfusion structure of hPIV3 F 21; 32. Trimers are 
shown side by side with single protomers. (E) Domain dV in HSV-1 gB is shown in orange 
in the postfusion structure. The prefusion model of HSV-1 gB, including the hypothetical 
location of domain V, is shown schematically. Trimers are shown side by side with single 
protomers. dV truncations would occur within the orange stalk. (F) Truncation of dV (top) 
was expected to destabilize the postfusion form of gB with a minimal effect on the stability 
of the prefusion form of gB while the replacement of the dV with GCNt was expected to 
substitute the native helical stalk with an engineered one (bottom).
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Fig. 3. 
Most constructs are secreted from insect cells and are not misfolded. Proteins secreted into 
the supernatant (A) or remaining inside the cells (B) were detected by Western blot with 
anti-gB polyclonal antibody R68. Under nonreducing denaturing conditions, gB migrates as 
a monomer (M). Positions of molecular weight standards are labeled. Lanes are labeled at 
the top. gB730-GCNt-cyto lane corresponds to construct gB730-GCNt-cyto(821–904).
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Fig. 4. 
Most constructs react with anti-gB monoclonal antibody DL16, specific for the postfusion 
form. (A) Mutants designed to stabilize the prefusion conformation. (B) Mutants designed to 
destabilize the postfusion conformation. Proteins secreted into the supernatant were detected 
by a Western blot with anti-gB monoclonal antibodies DL16 (top panels) or C226 (bottom 
panels). Under nonreducing mildly denaturing conditions, gB migrates as a trimer. T – 
trimer, M – monomer. Positions of molecular weight standards are labeled. In A, lanes are 
numbered and corresponding constructs are listed underneath the blots. “L6” stands for 
linker sequence GSGTGS; “L10” stands for linker sequence GGSGGTGGSG. “Cyto” 
corresponds to the entire gB cytoplasmic domain. In B, lanes are labeled at the top.
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Fig. 5. 
(A). Overlay of size-exclusion chromatograms of WT gB ectodomain (gB730) and 
representative mutants. gB trimer elutes as a broad peak near the void volume. The elution 
volumes of the void and the molecular weight standards are shown (arrows).
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Fig. 6. 
(A). All of the tested constructs adopted the postfusion conformation. gB molecules were 
visualized by negative-stain EM, and representative point mutants (A–C, H–I), 
“trimerization” constructs (D–G), and a truncation mutant (J) are shown. gB730-GCNt 
corresponds to construct gB730-GGSGGTGGSG-GCNt-Xa-His6, gB730-GCNt-cyto 
corresponds to construct gB730- GCNt-cyto(821-904), gB730-cyto corresponds to construct 
gB730-GSGTGS-cyto(796-904), and gB730-foldon corresponds to construct gB730-GSGS-
foldon. Electron micrographs with multiple particles as well as close-up views of individual 
particles are shown. All large panels and all close-up panels are shown at the same 
magnification levels, respectively. (K) The crystal structure of gB730 is shown in surface 
representation, for comparison. Crown and base ends are labeled.
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Fig. 7. 
Several mutations affect the stability of the postfusion trimer. (A) Thermal denaturation 
stability of gB730, L700G/L711G, and gB730-GCNt-cyto(821-904) as monitored by 
measuring change in the CD signal at 218 nm with increasing temperature. Data are shown 
as fraction unfolded vs. temperature. (B) Thermal denaturation stability of gB730, L700G/
L711G, and gB730-GCNt-cyto(821-904) as determined by Thermofluor assay. Data are 
shown as the first derivative of absorbance at 610 nm, in absorbance units per C, vs. 
temperature. (C) Oligomeric state of gB730 and several purified mutant proteins as analyzed 
by SDS-PAGE under mildly denaturing conditions (0.1% SDS, no boiling). Similar protein 
amounts were loaded into each lane. T – trimer, M – monomer. Positions of molecular 
weight standards are labeled.
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Fig. 8. 
Mutations in the gB Quad mutant do not affect the overall conformation of the gB 
ectodomain and cause only small local changes. (A) Crystal structure of the gB Quad mutant 
ectodomain (yellow) overlaid onto the structure of the WT gB (cyan). Only a single 
protomer (chain A) is shown. (B) A close-up view of the mutated region. Mutated residues 
are shown as sticks and labeled. (C) In gB Quad mutant, the side chain of F503 relocates to 
fill the void formed by R505G mutation. (D) A close-up view of the hydrogen bonds 
between the N-terminus of the central -helix αC in domain dIII (magenta) and domains dII 
and dV in the WT gB and gB Quad. Mutations eliminated all but one hydrogen bond. 
Residues involved in hydrogen bonds are shown as sticks and labeled. Hydrogen bonds are 
shown as dashed lines.
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Table 1
Summary of mutants’ properties
All gB constructs were expressed in Sf9 cells infected with recombinant baculoviruses. Expression was 
assessed by Western blots of infected supernatants using an anti-gB pAb R68. Trimerization was assessed by 
detection of trimeric form of protein by C226 or DL16 antibodies using P1 refeed samples prepared under 
mildly denaturing conditions (0.1% SDS, no reducing agent, no boiling). Xa - factor Xa protease cleavage site, 
His6 - hexahistidine tag, Strep - streptag.
Construct Expression Trimer C226/DL16
Mutants to stabilize the prefusion conformation
gB773-foldon + + +/+
gB773-foldon-Xa-His6 + + +/+
gB773-GSGTGS-foldon-Xa-His6 + + +/+
gB773-GGSGGTGGSG-foldon + + +/+
gB773-GGSGGTGGSG-foldon-Xa-His6 + + +/+
gB773-foldon-strep + + +/+
gB773-GSGTGS-foldon-strep + + +/+
gB773-GGSGGTGGSG-foldon-strep + + +/+
gB773-GCNt + + +/+
gB773-GSGTGS-GCNt-Xa-His6 + + +/+
gB773-GGSGGTGGSG-GCNt-Xa-His6 + + +/+
gB773-GSGTGS-cyto(796-904)-His6 + + +/+
gB773-GGSGGTGGSG-cyto(796-904)-His6 + + +/+
gB730-GSGS-foldon + + +/+
gB730-GSGTGS-foldon-Xa-His6 + + +/+
gB730-GGSGGTGGSG-foldon-Xa-His6 + + +/+
gB730-GSGTGS-GCNt-Xa-His6 + + +/+
gB730-GGSGGTGGSG-GCNt-Xa-His6 + + +/+
gB730-GCNt-cyto(821-904) + + +/+
gB730-GCNt-cyto(796-904) + + +/+
gB730-GSGTGS-cyto(796-904) + + +/+
gB730-GSGTGS-cyto(796-904)-His6 + + +/+
gB730-GGSGGTGGSG-cyto(796-904)-His6 + + +/+
Mutants to destabilize the postfusion conformation
E502A + + +/+
R505A + + +/+
Q507A + + +/+
N511A + + +/+
I391P + + +/+
T394P + − +/−
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Construct Expression Trimer C226/DL16
A504P/R505G/Q507G/N511G (Quad) + + +/+
A504P/R505G/L506F/Q507G/T509F/N511G (Quad-FF) + + +/+
A504P/R505G/L506W/Q507G/T509W/N511G (Quad-WW) + + +/−
L506F + + +/+
T509F + + +/+
I513F + + +/+
L506K + + +/+
R515P + + +/+
L700G/L711G + + +/−
gB670 + − +/−
gB678 + + +/−
gB683 + + +/−
gB689 + + +/−
gB700 + + +/−
gB684-GGSGGTGGSG-GCNt-Xa-His6 − N/D N/D
gB690-GGSGGTGGSG-GCNt-Xa-His6 − N/D N/D
gB701-GGSGGTGGSG-GCNt-Xa-His6 − N/D N/D
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Table 2
Data collection and refinement statistics for the gB Quad mutant Data collection
Space group P3
Cell dimensions, (Å, °) 117.295, 117.295, 321.872, 90, 90, 120
Wavelength, (Å) 1.1000
Resolution (Å) 45.91-3.10 (3.21-3.10)a
Total reflections 149,982
Unique reflections 74,374 (7834)a
Completeness (%) 82.8 (87.5)a
I/σI 10.25 (3.00)a
Redundancy 2.0 (1.9)a
Rmerge 0.067 (0.236)a
Refinement
Resolution (Å) 45.91-3.10
Rwork/Rfree 0.2052/0.2549
No. atoms
Protein 19615
Ligand/ion 20
Solvent 18
Average B-factors (Å2)
Protein 45.4
Ligand/ion 41.4
Solvent 19.3
R.m.s. deviations
Bond lengths (Å) 0.009
Bond angles (°) 1.205
Ramachandran plot (%)b
Most favored region 90.8
Additionally allowed region 10.0
Disallowed region 0.2
aValues in parentheses are for the highest-resolution shell
b
Determined using Molprobity 43
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